Clinical Trial Update: Azithromycin in the Prevention of Lung Injury in Premature Newborn [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating azithromycin for the prevention of lung injury, specifically bronchopulmonary dysplasia, in premature newborns has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• Azithromycin (azithromycin)

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Bronchopulmonary Dysplasia | Phase 4 | Status: COMPLETED